Skip to main content
CBIO logo

CBIO · Crescent Biopharma, Inc. · Documents

Track CBIO — free
$13.00 +0.09 (+0.70%) At close · Nov 20
Market Cap
$505.64M
Shares
38.90M
Volume · Nov 20 422.38K Avg daily vol (3M) 358.97K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2024
Mar 27
Annual report 10-K FY2023, ended Dec 31
Annual report for FY2023
Revenue $10K ▼ 86.7% Net loss $36.9M Diluted EPS -$0.58
2023
Mar 29
Annual report 10-K FY2022, ended Dec 31
Annual report for FY2022
Revenue $75K ▼ 93.5% Net loss $46.69M Diluted EPS -$0.89
2022
Mar 3
Annual report 10-K FY2021, ended Dec 31
Annual report for FY2021
Revenue $1.16M ▼ 88.6% Net loss $63.43M Diluted EPS -$1.23
2021
Showing 51–100 of 121 documents
Key facts CIK 1253689 CUSIP G2545C104 13F (30d) 102 filings 99 filers Visit website Investor relations